TABLE 1.
Species and antimicrobial agent (no. of isolates) | MIC (μg/ml)a |
||
---|---|---|---|
Range | 50% | 90% | |
Desulfovibrio spp. (n = 23) | |||
Antianaerobic | |||
Sulbactam-ampicillin | 0.064-6 | 0.38 | 6 |
Piperacillin | 32->256 | >256 | >256 |
Piperacillin-tazobactam | 16->256 | >256 | >256 |
Cefoxitin | 16->256 | >256 | >256 |
Cefotaxime | 0.047->256 | 1.5 | >256 |
Meropenem | 0.023-12 | 0.19 | 4 |
Clindamycin | 0.016-0.25 | 0.125 | 0.19 |
Chlorampenicol | 1.5-12 | 4 | 8 |
Metronidazole | <0.016-1.5 | 0.125 | 0.25 |
Others | |||
Ampicillin | 0.19-24 | 0.75 | 8 |
Cefoperazone | 12->256 | >256 | >256 |
Sulbactam-cefoperazone | 1->256 | 4 | >256 |
Cefalothin | 16->256 | >256 | >256 |
Ceftazidime | 2->256 | 6 | >256 |
Cefpirome | 0.5->256 | 4 | >256 |
Erythromycin | 0.064-4 | 0.5 | 1.5 |
Minocycline | 0.19-24 | 6 | 24 |
Ciprofloxacin | 0.125->32 | 0.5 | >32 |
Levofloxacin | 0.094->32 | 0.75 | >32 |
Sulfamethoxazole-trimethoprim | >32 | >32 | >32 |
D. fairfieldensis (n = 8)b | |||
Antianaerobic | |||
Sulbactam-ampicillin | 4-6 | ||
Piperacillin | >256 | ||
Piperacillin-tazobactam | >256 | ||
Cefoxitin | 64->256 | ||
Cefotaxime | 0.047->256 | ||
Meropenem | 2-12 | ||
Clindamycin | 0.032-0.19 | ||
Chloramphenicol | 3-6 | ||
Metronidazole | <0.016-0.38 | ||
Others | |||
Ampicillin | 4-8 | ||
Cefoperazone | >256 | ||
Sulbactam-cefoperazone | 24->256 | ||
Cefalothin | >256 | ||
Ceftazidime | >256 | ||
Cefpirome | >256 | ||
Erythromycin | 0.5-4 | ||
Minocycline | 4-24 | ||
Ciprofloxacin | >32 | ||
Levofloxacin | >32 | ||
Sulfamethoxazole-trimethoprim | >32 | ||
D. desulfuricans Essex 6 (n = 7)c | |||
Antianaerobic | |||
Sulbactam-ampicillin | 0.125-1.5 | ||
Piperacillin | >256 | ||
Piperacillin-tazobactam | 16->256 | ||
Cefoxitin | >256 | ||
Cefotaxime | 0.047-6 | ||
Meropenem | 0.064-0.25 | ||
Clindamycin | 0.094-0.25 | ||
Chloramphenicol | 1.5-12 | ||
Metronidazole | 0.064-1.5 | ||
Others | |||
Ampicillin | 0.19-2 | ||
Cefoperazone | 16->256 | ||
Sulbactam-cefoperazone | 3->256 | ||
Cefalothin | 3->256 | ||
Ceftazidime | 3->256 | ||
Cefpirome | 0.5-32 | ||
Erythromycin | 0.38-0.75 | ||
Minocycline | 2-12 | ||
Ciprofloxacin | 0.19-2 | ||
Levofloxacin | 0.25-3 | ||
Sulfamethoxazole-trimethoprim | >32 | ||
D. desulfuricans MB (n = 6)d | |||
Antianaerobic | |||
Sulbactam-ampicillin | 0.064-0.25 | ||
Piperacillin | 32->256 | ||
Piperacillin-tazobactam | 32-96 | ||
Cefoxitin | 16->256 | ||
Cefotaxime | 0.5-1.5 | ||
Meropenem | 0.023-0.064 | ||
Clindamycin | 0.094-0.19 | ||
Chloramphenicol | 1.5-4 | ||
Metronidazole | 0.016-0.38 | ||
Others | |||
Ampicillin | 0.19-0.38 | ||
Cefoperazone | 12-24 | ||
Sulbactam-cefoperazone | 1-3 | ||
Cefalothin | 2-6 | ||
Ceftazidime | 2-4 | ||
Cefpirome | 0.5-2 | ||
Erythromycin | 0.38-1 | ||
Minocycline | 3-8 | ||
Ciprofloxacin | 0.125-0.38 | ||
Levofloxacin | 0.25-0.5 | ||
Sulfamethoxazole-trimethoprim | >32 | ||
D. piger (n = 2)e | |||
Antianaerobic | |||
Sulbactam-ampicillin | 0.5-1 | ||
Piperacillin | >256 | ||
Piperacillin-tazobactam | >256 | ||
Cefoxitin | 16 | ||
Cefotaxime | 1-1 | ||
Meropenem | 0.032-0.19 | ||
Clindamycin | 0.016-0.016 | ||
Chloramphenicol | 1.5-3 | ||
Metronidazole | 0.032-0.5 | ||
Others | |||
Ampicillin | 12-32 | ||
Cefoperazone | 12-32 | ||
Sulbactam-cefoperazone | 1-1.5 | ||
Cefalothin | 96->256 | ||
Ceftazidime | 3-3 | ||
Cefpirome | 0.75-4 | ||
Erythromycin | 0.016-0.125 | ||
Minocycline | 0.19-1 | ||
Ciprofloxacin | 0.125-0.19 | ||
Levofloxacin | 0.095-0.125 | ||
Sulfamethoxazole-trimethoprim | >32 |
50% and 90%, MIC50 and MIC90, respectively.
One isolate from pouchitis, five from stool specimens, and two from tongue coating.
One isolate from appendicitis, two from stool specimens, and four from tongue coating.
One isolate from blood, three from pouchitis, and two from appendicitis.
Both isolates from pouchitis.